<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<!--  Enhancement and balance of 1,4 butanediamine biosynthesis in Escherichia coli based on modular metabolic engineering ( 23 ) -->
<METS:mets OBJID=""
  xmlns:METS="http://www.loc.gov/METS/"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:mods="http://www.loc.gov/mods/v3"
  xmlns:sobekcm="http://sobekrepository.org/schemas/sobekcm/"
  xmlns:lom="http://sobekrepository.org/schemas/sobekcm_lom"
  xsi:schemaLocation="http://www.loc.gov/METS/
    http://www.loc.gov/standards/mets/mets.xsd
    http://www.loc.gov/mods/v3
    http://www.loc.gov/mods/v3/mods-3-4.xsd
    http://sobekrepository.org/schemas/sobekcm/
    http://sobekrepository.org/schemas/sobekcm.xsd">
<METS:metsHdr CREATEDATE="2026-10-14T06:10:38Z" ID="" LASTMODDATE="2026-10-14T06:10:38Z" RECORDSTATUS="COMPLETE">
</METS:metsHdr>
<METS:dmdSec ID="DMD1">
<METS:mdWrap MDTYPE="MODS"  MIMETYPE="text/xml" LABEL="MODS Metadata">
<METS:xmlData>
<mods:mods>
<mods:genre authority="sobekcm">23</mods:genre>
<mods:identifier>DOI: https://doi.org/10.1016/j.jgeb.2026.100780</mods:identifier>
<mods:language>
<mods:languageTerm type="text">English</mods:languageTerm>
<mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
</mods:language>
<mods:name>
<mods:namePart>Xiangxiang Sun</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">Contributor</mods:roleTerm>
</mods:role>
</mods:name>
<mods:note>&lt;p&gt;&lt;span style=&quot;color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;1,4-Butanediamine is an important raw material for the synthesis of engineering plastics such as Polyamide 46 with excellent performance, which is widely used in automotive, electronics and machinery manufacturing industries. In this study, &lt;/span&gt;&lt;em style=&quot;margin: 0px; padding: 0px; color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;Escherichia coli&lt;/em&gt;&lt;span style=&quot;color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt; BL21(DE3) was used as the starting strain to systematically modify the 1,4-butanediamine biosynthesis pathway using a modular strategy. 1,4-Butanediamine biosynthesis was re-divided into two modules: 1,4-butanediamine production module and α-ketoglutaric acid production module. By controlling the expression intensity of genes &lt;/span&gt;&lt;em style=&quot;margin: 0px; padding: 0px; color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;pykF, ppc, aceEF, gltA, icdA&lt;/em&gt;&lt;span style=&quot;color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt; and &lt;/span&gt;&lt;em style=&quot;margin: 0px; padding: 0px; color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;gdhA, argD, argCB, argJ, ODC10&lt;/em&gt;&lt;span style=&quot;color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;, a recombinant producing 1,4-butanediamine strain PKT was obtained, achieving a yield of 862.82 mg/L of 1,4-butanediamine, which increased 8.62-fold compared to that of &lt;/span&gt;&lt;em style=&quot;margin: 0px; padding: 0px; color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt;Escherichia coli&lt;/em&gt;&lt;span style=&quot;color: rgb(31, 31, 31); font-family: ElsevierGulliver, Georgia, &quot;Times New Roman&quot;, Times, STIXGeneral, &quot;Cambria Math&quot;, &quot;Lucida Sans Unicode&quot;, &quot;Microsoft Sans Serif&quot;, &quot;Segoe UI Symbol&quot;, &quot;Arial Unicode MS&quot;, serif, sans-serif; font-size: 16px;&quot;&gt; BL21(DE3). Then, the fermentation medium of PKT strain was optimized. After 24 h of fermentation, the yield of 1,4-butanediamine reached 1843.60 mg/L, representing a 16.23-fold increase over the original strain. Furthermore, non-target metabolomics analysis was used to analyze the changes of metabolites during the efficient synthesis of 1,4-butanediamine by the recombinant strain PKT. The results showed that the total number of differential metabolites detected was 653. Differential metabolite pathway analysis showed that there were 9 differential metabolites in the 1,4-butanediamine synthesis pathway, with 5 involved in its synthesis pathway and 4 in its degradation branch. These differences in metabolites provide a theoretical basis for the modification of recombinant strains. The green production of 1,4- butanediamine by microbial cell factories through fermentation is the future direction. This research provides a theoretical guidance of building high yield 1,4-butanediamine engineering strains.&lt;/span&gt;&lt;/p&gt;</mods:note>
<mods:originInfo>
<mods:publisher>Elsevier </mods:publisher>
<mods:dateIssued>September 2026</mods:dateIssued>
</mods:originInfo>
<mods:relatedItem type="original">
<mods:physicalDescription>
<mods:extent>pdf</mods:extent>
</mods:physicalDescription>
</mods:relatedItem>
<mods:subject>
<mods:geographic></mods:geographic>
</mods:subject>
<mods:subject>
<mods:topic>Journal of Genetic Engineering and Biotechnology</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Enhancement and balance of 1,4-butanediamine biosynthesis in Escherichia coli based on modular metabolic engineering</mods:title>
</mods:titleInfo>
<mods:typeOfResource>mixed material</mods:typeOfResource>
</mods:mods>
</METS:xmlData>
</METS:mdWrap>
</METS:dmdSec>
<METS:dmdSec ID="DMD2">
<METS:mdWrap MDTYPE="OTHER"  OTHERMDTYPE="SOBEKCM" MIMETYPE="text/xml" LABEL="SobekCM Custom Metadata">
<METS:xmlData>
<sobekcm:procParam>
</sobekcm:procParam>
<sobekcm:bibDesc>
<sobekcm:Publisher>
<sobekcm:Name>Elsevier </sobekcm:Name>
</sobekcm:Publisher>
</sobekcm:bibDesc>
</METS:xmlData>
</METS:mdWrap>
</METS:dmdSec>
<METS:structMap ID="STRUCT1" > <METS:div /> </METS:structMap>
</METS:mets>
